Robert W. Baird Issues Positive Forecast for Owens & Minor (NYSE:OMI) Stock Price

Owens & Minor (NYSE:OMI) had its target price hoisted by Robert W. Baird from $10.00 to $11.00 in a report released on Monday,Benzinga reports. The firm currently has a neutral rating on the stock.

A number of other analysts have also issued reports on OMI. Citigroup cut their target price on Owens & Minor from $21.00 to $18.50 and set a “buy” rating on the stock in a research report on Tuesday, November 5th. Barclays cut their target price on Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating on the stock in a research report on Tuesday, November 5th. Finally, UBS Group cut their target price on Owens & Minor from $25.00 to $13.00 and set a “buy” rating on the stock in a research report on Thursday, February 13th. Two analysts have rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, Owens & Minor has an average rating of “Hold” and a consensus price target of $15.08.

Owens & Minor Trading Down 2.7 %

OMI opened at $9.32 on Monday. Owens & Minor has a one year low of $6.07 and a one year high of $28.35. The stock has a market capitalization of $718.66 million, a PE ratio of -14.34, a P/E/G ratio of 0.20 and a beta of 0.48. The business’s 50 day moving average price is $11.44 and its 200 day moving average price is $13.18. The company has a debt-to-equity ratio of 2.11, a quick ratio of 0.45 and a current ratio of 1.09.

Owens & Minor (NYSE:OMI) last released its quarterly earnings data on Friday, February 28th. The company reported $0.55 EPS for the quarter, beating analysts’ consensus estimates of $0.53 by $0.02. The firm had revenue of $2.70 billion for the quarter, compared to analysts’ expectations of $2.68 billion. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. The firm’s quarterly revenue was up 1.5% on a year-over-year basis. During the same period in the prior year, the firm posted $0.69 earnings per share. As a group, equities research analysts expect that Owens & Minor will post 1.51 EPS for the current year.

Owens & Minor announced that its board has authorized a share repurchase program on Friday, February 28th that authorizes the company to buyback $100.00 million in outstanding shares. This buyback authorization authorizes the company to reacquire up to 13.6% of its shares through open market purchases. Shares buyback programs are typically a sign that the company’s management believes its shares are undervalued.

Institutional Trading of Owens & Minor

A number of large investors have recently modified their holdings of the stock. FMR LLC increased its position in shares of Owens & Minor by 0.8% during the third quarter. FMR LLC now owns 11,564,624 shares of the company’s stock worth $181,449,000 after acquiring an additional 90,862 shares during the period. Vanguard Group Inc. grew its stake in shares of Owens & Minor by 1.2% during the fourth quarter. Vanguard Group Inc. now owns 8,915,756 shares of the company’s stock worth $116,529,000 after purchasing an additional 107,092 shares in the last quarter. Coliseum Capital Management LLC grew its stake in shares of Owens & Minor by 31.3% during the fourth quarter. Coliseum Capital Management LLC now owns 4,785,964 shares of the company’s stock worth $62,553,000 after purchasing an additional 1,141,483 shares in the last quarter. State Street Corp grew its stake in shares of Owens & Minor by 2.6% during the third quarter. State Street Corp now owns 3,064,547 shares of the company’s stock worth $48,083,000 after purchasing an additional 78,985 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. grew its stake in shares of Owens & Minor by 13.6% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,305,043 shares of the company’s stock worth $30,127,000 after purchasing an additional 276,807 shares in the last quarter. Hedge funds and other institutional investors own 98.04% of the company’s stock.

Owens & Minor Company Profile

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.